This course is an updated of the NIDA/SAMHSA’s Blending Initiative product, originally titled “Buprenorphine Treatment: A Training for Multidisciplinary Professionals”. The primary goal is to create awareness among addiction professionals about medications currently approved by the FDA and used in the treatment of opioid dependence. It includes information about what to expect when someone is treated with medication, information about the legislation that permits office-based buprenorphine treatment, the science of addiction, the mechanism of each medication, patient selection criteria and associated patient counseling and therapeutic issues.
LEARNING OBJECTIVES:
•Review the history of opioid treatment in the US;
•Discuss changes in the laws regarding treatment of opioid addiction;
•Learn how medication will benefit the delivery of opioid treatment and the types of medications used to treat opioid use disorder.